View up-to-date information on Allogene Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 11 Jan 2022 | Allogene Therapeutics Enters into Licensing Agreement with Antion Biosciences | Licensing Agreement |
Allogene Therapeutics Inc
|
Antion Biosciences SA
|
| 10 Feb 2021 | Notch Therapeutics Raises USD85 Million in Series A Financing | Venture Financing |
Lumira Capital Investment Management Inc
Samsara BioCapital LLC
Casdin Capital LLC
Centre for Commercialization of Regenerative Medicine
Amplitude Ventures Inc
Allogene Therapeutics Inc
EcoR1 Capital LLC
|
Notch Therapeutics Inc
|
| 15 Dec 2020 | Allogene Therapeutics and Overland Pharma Form Joint Venture | Partnership |
Allogene Overland Biopharm
|
Overland Pharmaceuticals
Allogene Therapeutics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer